Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Jaguar Health Inc (JAGX)

2.92   -0.35 (-10.7%) 01-21 00:50
Open: 3.1038 Pre. Close: 3.27
High: 3.13 Low: 2.8
Volume: 26,059,118 Market Cap: 344M
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The company is headquartered in San Francisco, California and currently employs 17 full-time employees. The firm is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.135 - 3.157 3.157 - 3.173
Low: 2.747 - 2.775 2.775 - 2.796
Close: 2.881 - 2.919 2.919 - 2.948

Technical analysis

as of: 2021-01-20 4:48:57 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.22     One year: 6.10
Support: Support1: 1.91    Support2: 0.32
Resistance: Resistance1: 4.47    Resistance2: 5.22
Pivot: 2.54
Moving Average: MA(5): 3.30     MA(20): 2.07
MA(100): 0.66     MA(250): 0.60
MACD: MACD(12,26): 0.76     Signal(9): 0.69
Stochastic oscillator: %K(14,3): 65.73     %D(3): 69.57
RSI: RSI(14): 63.74
52-week: High: 4.47  Low: 0.19  Change(%): 262.7
Average Vol(K): 3-Month: 5932403  10-Days: 7956943

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
JAGX has closed below upper band by 41.4%. Bollinger Bands are 587.5% wider than normal. The large width of the bands suggest high volatility as compared to JAGX's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue.

Headline News

Wed, 20 Jan 2021
Jaguar Health Announces Closing of $6.0 Million Issuance and Sale of Designation-backed Note Related to Possible Tropical Disease Priority Review Voucher - Yahoo Finance

Fri, 15 Jan 2021
Jaguar Health Provides Replay Link & High-level Overview of January 14th Investor Webcast - Yahoo Finance

Thu, 14 Jan 2021
Jaguar Health Inc (JAGX) Stock: Buy, Hold, or Sell? - InvestorsObserver

Wed, 13 Jan 2021
Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules - Yahoo Finance

Tue, 12 Jan 2021
Jaguar Health to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference the Week of January 11th and at 4:30 pm Eastern on Tuesday, January 19th at the NobleCon17 Virtual Conference - Yahoo Finance

Tue, 12 Jan 2021
Don't Try to Tame Jaguar Health Stock As It Rips Higher - InvestorPlace

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 107
Shares Float (M) 63
% Held by Insiders 8.01
% Held by Institutions 6.70
Shares Short (K) 2,310
Shares Short P. Month (K) 429

Stock Financials

EPS -1.551
EPS Est This Year -0.680
EPS Est Next Year -0.220
Book Value (p.s.) 0.040
Profit Margin
Operating Margin -266.17
Return on Assets (ttm) -38.5
Return on Equity (ttm) -220.0
Qtrly Rev. Growth 185.0
Gross Profit (p.s.) -0.035
Sales Per Share 0.078
EBITDA (p.s.) -0.190
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -1.88
PEG Ratio
Price to Book value 73.00
Price to Sales 37.67
Price to Cash Flow -21.83

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.